Archive · 30 Sep 2025
China's Import Duty Removal Boosts Indian Pharma
China has decided to stop charging import taxes on medicines and other products from India.
This is good news for Indian companies that make these products, like medicine.
Because China is such a large country, the duty free access is a major opportunity, especially since other countries like the US are becoming more expensive to sell to.
According to Dr. Yeluri Ramachandra Reddy, the joint secretary of BDMAI, this will help India's economy grow and give India a better place in the worldwide healthcare market, making them even more known for their quality products.
This will likely result in more trade, more money being invested, and more jobs in the Indian pharmaceutical industry.
China removed the 30% import duty on Indian pharma products.
This allows duty-free exports from India to China.
It provides an alternative market to the US.
The decision is expected to boost India-China trade and economic growth.
It could lead to increased exports, investment, and jobs.
- Who
- Dr. Yeluri Ramachandra Reddy
- What
- China eliminated the 30% import duty on pharmaceutical products from India.
- When
- Not explicitly stated, but a recent event.
- Where
- China
- Why
- To open new opportunities and boost the pharmaceutical industry.
- Event
- China removes 30% import duty on Indian pharmaceutical products
- Impact
- Duty-free exports for Indian companies
- Advocate
- Dr. Yeluri Ramachandra Reddy, Joint Secretary, BDMAI
- Expected Outcome
- Increased exports, investment, and job creation
- Benefit
- Strengthened India-China trade, economic growth